Revance Therapeutics Inc (RVNC)

[usma67korea]

if RVNC hits $60M for Q2 (forecast is for 66M+ which is 13.8% yoy increase only), shares will get hammered again. Q1 is weakest Q in revenue annually, so using Q1 revenue of 51M and to grow 15% QoQ is not quite the estimate I would use. 15% yoy Q2 increase from 2023 would be more suitable target. whether they hit it I don't know but that's how I see it